Event details

Date

Time

Duration

Thursday 28 January

23:00 pm - 1:30 (PST – Jan 27)
2:00 - 4:30 (EST)
7:00 - 9:30 (GMT)
16:00 - 18:30 (JST)

2.5 Hours

Overview:

Type 2 immunological diseases such as asthma, food allergies and atopic dermatitis have all demonstrated dramatic rises in recent decades and exert a heavy burden on health systems worldwide. However, with a greater understanding of the immunological processes giving rise to these diseases, come opportunities to identify and treat them with greater efficacy and specificity. Accordingly, the Japanese government in collaboration in scientists, clinicians, industries and patients have identified the effective treatment of allergic diseases as a major unmet clinical need.

This multidisciplinary virtual Nature Conference will bring together prominent experts from around the world to discuss the latest developments in type 2 immunological diseases and their treatment. The meeting will conclude with a ‘cross-reality’ social gathering and poster session which will allow delegates to meet and interact in a 3-dimensional setting.

Type 2 immunity: challenges and opportunities

16:00 – 16:05 JST	Welcoming Remarks Ken Ishii, IMSUT, The University of Tokyo
Session Chair:	Cezmi Akdis & Toshinori Nakayama
16:05 – 16:20 JST	Strategic Outlook toward 2030: Japan's research for allergy and immunology Takeya Adachi, UJA/Kyoto Prefectural University of Medicine
16:20 – 16:35 JST	DCs and asthma Bart Lambrecht, ErasmusMC, UGent
16:35 – 16: 50 JST	Neutrophils/NETosis, viral aggravation of type II immunity Thomas Marichal, Liege University
16:50 – 17:00 JST	Break
Session Chair:	Cevayir Coban & Hiroshi Kiyono
17:00 – 17:15 JST	Mechanisms of immune tolerance to allergens; Role of B regulatory cells Mubeccel Akdis, Swiss Institute of Allergy and Asthma Research
17:15 – 17:30 JST	Epigenetics, microbiota, and T cell differentiation Hiroko Nakatsukasa, Keio University School of Medicine
17:30 – 17:45 JST	Nucleic acid-based immune-prophylaxis against viral infection Kouji Kobiyama, IMSUT, The University of Tokyo
17:45 – 18:15 JST	Discussion and Q&A Zoltan Fehervari, Nature Immunology
18:15 – 18:20 JST	Closing remarks
18:20 – 18:30 JST	Break
18:30 – 20:00 JST	Cross-Reality (XR) social gathering with poster sessions (separate registration is required)

Event Sponsors

Thank you to our sponsors.

Registration

Full Name

First Name

Last Name

Organization

Job Title

Country

Do you wish to receive further information from Nature Research about Nature Conferences and Events? Yes No

Would you like to receive emails from our event partner, The Institute of Medical Science, The University of Tokyo? Yes No

If you have a disability and require special assistance to participate in the conference, please enter your requirements here.

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Event details

Welcoming Remarks

Ken Ishii, IMSUT, The University of Tokyo

Cezmi Akdis & Toshinori Nakayama

Strategic Outlook toward 2030: Japan's research for allergy and immunology

Takeya Adachi, UJA/Kyoto Prefectural University of Medicine

DCs and asthma

Bart Lambrecht, ErasmusMC, UGent

Neutrophils/NETosis, viral aggravation of type II immunity

Thomas Marichal, Liege University

Break

Cevayir Coban & Hiroshi Kiyono

Mechanisms of immune tolerance to allergens; Role of B regulatory cells

Mubeccel Akdis, Swiss Institute of Allergy and Asthma Research

Epigenetics, microbiota, and T cell differentiation

Hiroko Nakatsukasa, Keio University School of Medicine

Nucleic acid-based immune-prophylaxis against viral infection

Kouji Kobiyama, IMSUT, The University of Tokyo

Discussion and Q&A

Zoltan Fehervari, Nature Immunology

Closing remarks

Break

Cross-Reality (XR) social gathering with poster sessions(separate registration is required)

Registration

Cross-Reality (XR) social gathering with poster sessions
(separate registration is required)